You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

477 Items

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events

Document Status: In-Review
ID: 12-12-2
Version: 2

Nov 2018

Safe Handling of Hazardous Drugs

Document Status: Current
ID: GL 16-3
Version: 3

Mar 2022

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Document Status: Current
Version: 1

Jun 2018

Screening for Lynch Syndrome by Immunohistochemistry, BRAF Mutations Analysis, and MLH1 Promoter Methylation Analysis for Patients in Ontario with Colorectal or Endometrial Cancers

Document Status: Archived
ID: MOAC 3

Sep 2015

Screening for Secondary Solid Malignancies after Stem Cell Transplant

Document Status: Current
Version: 2

Mar 2022

Screening for Skin Cancer

Document Status: Education and Information
ID: 15-1

Jun 2007

Screening High-Risk Populations for Lung Cancer

Document Status: Archived
ID: 15-10

Apr 2013

Screening High-Risk Women for Ovarian Cancer

Document Status: Archived
ID: 4-6b

Aug 2004

Screening Postmenopausal Women for Ovarian Cancer

Document Status: Archived
ID: 4-6a

Jan 2014

Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Lung Cancer

Document Status: Archived
ID: 7-19

Oct 2012

Self-collected Samples for Testing of Oncogenic Human Papillomavirus

Document Status: Archived
ID: HPVTest

Apr 2006

Self-Management Education for Patients with Cancer: Evidence Summary

Document Status: Archived
ID: 20-3

Jan 2016